AUAUniversity12 Jul 2019

AUA2019 048IC Novel Agents & Concepts In The Management Of Hormone Naïve & CRPC

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genomic Health, Genentech, Merck, Pfizer, Inc. and Sanofi Genzyme CME Available: https://auau.auanet.org/content/novel-agents-concepts-management-hormone-na%C3%AFve-castrate-resistant-prostate-cancer-webcast-0 This course will include short didactic lectures followed by case presentations to give attendees an understanding of the many new FDA-approved agents, as well as existing standard therapies, for advanced prostate cancer-both non-metastatic and metastatic CRPC. Particular attention will be devoted to sequencing the new agents and positioning them as compared to older existing therapies. The cost effectiveness of new and existing agents will also be addressed. Learning Objectives: Diagnose both non-metastatic and metastatic castrate resistant prostate cancer (nmCRPC, mCRPC) and have a working knowledge of treatments and the proper order for administration. Manage nm and mCRPC with systemic agents by learning the proper candidates for treatment and be able to counsel patients on the pros and cons of therapy. Analyze the mechanism of action and risks/benefits of using systemic agents in the treatment of nm/mCRPC. Describe the bone-targeted, radiopharmaceutical agent and its sequencing. Review the newer generation antiandrogen agents and their use in nmCRPC and in mCRPC.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(461)

Core Curriculum: Pediatric Oncology

Core Curriculum: Pediatric Oncology Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Amanda F. Buchanan, MD AUA Urology Core Curriculum: https://cme.auanet.org/Page/Core-Curriculum Outline: Segment 1: R...

30 Sep 30min

Starting HoLEP without Fellowship Training

Starting HoLEP without Fellowship Training Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Daniel S. Kellner, MD

23 Sep 26min

AUA Guidelines: Vasectomy

AUA Guidelines: Vasectomy Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Richard Lee, MD, MBA To access the full guideline, please use the following link: https://www.auanet.org/guidelines-and-quality/...

16 Sep 24min

Microultrasound for the Detection of Prostate Cancer

Microultrasound for the Detection of Prostate Cancer Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Christian P. Pavlovich, MD

9 Sep 24min

AUA Guidelines: Non-Muscle Invasive Bladder Cancer

AUA Guidelines: Non-Muscle Invasive Bladder Cancer Host: Mark L. Gonzalgo, MD, PhD, MBA Guests: Peter E. Clark, MD and Jeffrey M. Holzbeierlein, MD, FACS To access the full guideline, please use th...

3 Sep 33min

Update Series (2026): Evaluating Abnormal Urine Cytology Without Clinically Demonstrable Urinary Tract Disease

Update Series (2026): Evaluating Abnormal Urine Cytology Without Clinically Demonstrable Urinary Tract Disease Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Sherri M. Donat, MD Now in its 45th install...

2 Sep 21min

AUA2026: Advanced Prostate Cancer in the News 2026: A Case-Based Multidisciplinary Update

AUA2026: Advanced Prostate Cancer in the News 2026: A Case-Based Multidisciplinary Update CME Available: https://cme.auanet.org/URL/26DC010ONL LEARNING OBJECTIVES: At the conclusion of this activity...

24 Aug 1h 31min

AUA2026: Should I Order a PET Scan? Integrating Molecular Imaging into Urologic Oncology

AUA2026: Should I Order a PET Scan? Integrating Molecular Imaging into Urologic Oncology Clinical Practice: Current Approaches and Future Opportunities CME Available: https://cme.auanet.org/URL/26DC0...

21 Aug 1h 47min